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Cellular FLICE-like inhibitory protein (c-FLIP, gene symbol CFLAR) was ﬁrst identiﬁed as a negative reg-
ulator of death receptor-mediated apoptosis in mammals. To understand the ubiquity and diversity of the
c-FLIP protein subfamily during evolution, c-FLIP orthologs were identiﬁed from a comprehensive range
of vertebrates, including birds, amphibians, and ﬁsh, and were characterized by combining experimental
and computational analysis. Predictions of three-dimensional protein structures and molecular phylo-
genetic analysis indicated that the conserved structural features of c-FLIP proteins are all derived from an
ancestral caspase-8, although they rapidly diverged from the subfamily consisting of caspases-8, -10, and
-18. The functional role of the c-FLIP subfamily members is nearly ubiquitous throughout vertebrates.
Exogenous expression of non-mammalian c-FLIP proteins in cultured mammalian cells suppressed death
receptor-mediated apoptosis, implying that all of these proteins possess anti-apoptotic activity. Fur-
thermore, non-mammalian c-FLIP proteins induced NF-κB activation much like their mammalian
counterparts. The CFLARmRNAs were synthesized during frog and ﬁsh embryogenesis. Overexpression of
a truncated mutant of c-FLIP in the Xenopus laevis embryos by mRNA microinjection caused thorax
edema and abnormal constriction of the abdomen. Depletion of cﬂar transcripts in zebraﬁsh resulted in
developmental abnormalities accompanied by edema and irregular red blood cell ﬂow. Thus, our results
demonstrate that c-FLIP/CFLAR is conserved in both protein structure and function in several vertebrate
species, and suggest a signiﬁcant role of c-FLIP in embryonic development.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).B.V. This is an open access article u
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Apoptotic cell death is essential for multicellular organisms. In
the apoptosis process, a family of cysteine proteases known as
caspases are activated and work as executors to induce the pro-
teolytic cleavage of many critical proteins leading cells to suicide
[1]. The activation of caspases converges from two major signaling
pathways: the extrinsic signaling pathway initiated by ligation of
the cell surface death receptors such as Fas (also called APO-1/
CD95) and the intrinsic signaling pathway triggered by cyto-
chrome c release from mitochondria into the cytosol by apoptotic
stimuli [2,3]. The Fas-mediated pathway is well characterized as
the representative extrinsic pathway. Oligomerization of Fas by its
natural ligand or an agonistic antibody recruits an adapter mole-
cule, Fas-associated death domain protein (FADD) to the death
domain within the intracellular region. The initiator caspase,nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(DED) motifs and a protease domain, caspase, interleukin-1 β
converting enzyme homologs (CASc), in turn associates with FADD
by way of an interaction between their respective DEDs. In the
complex composed of Fas-FADD-CASP8, CASP8 progresses through
an auto-processing step and transforms to an active form. Acti-
vated CASP8 subsequently processes and activates downstream
molecules, resulting in cell death.
Cellular FLICE-like inhibitory protein (c-FLIP; also called CFLAR,
CLARP, FLAME-1, I-FLICE, Casper, CASH, and Usurpin, gene symbol
CFLAR) is a negative regulator of Fas-induced apoptosis [4–11].
Mammalian c-FLIP exists as two alternatively spliced isoforms:
c-FLIP(L) (long form of c-FLIP) is homologous to CASP8, except it
lacks critical amino acids for proteolytic activity [8]; c-FLIP(S)
(short form of c-FLIP) consists of only two DED motifs. In humans,
a third isoform, c-FLIP Raji (c-FLIP(R)) was also identiﬁed [12].
These isoforms are able to bind directly to CASP8 by homophilic
interactions through their DED domains, and thereby regulate the
activation of CASP8 and apoptosis [12,13]. c-FLIP can also induce
Nuclear Factor-kappa B (NF-κB) activation [14,15]. In previous
studies, we and other groups have reported that both CFLAR and
CASP8 genes, along with their homologous genes caspase-10
(CASP10) and caspase-18 (CASP18), localize to the same chromo-
somal region in marsupials, birds, reptiles, and amphibians [16–
19]. Therefore, it is likely that these four genes are derived from an
ancestral gene by duplication during evolution. Interestingly, the
CASP18 gene is deleted in eutherian mammals, and the Casp10
gene is further deleted in rodents [16–18]. However, the CFLAR
gene as well as the CASP8 gene is found from ﬁsh to mammals,
suggesting that both are requisite in vertebrates.
In this study, we show both the conservation of the three-di-
mensional structure of c-FLIP proteins in vertebrates and the
functional universality in regulation of apoptosis and NF-κB sig-
naling. Furthermore, we clarify the action of c-FLIP proteins in
embryos of non-mammalian vertebrates, pointing to an important
role during embryonic development. Based on these results, we
propose the uniqueness of c-FLIP relative to its paralogous mole-
cules, as well as its conserved function through vertebrate
evolution.2. Materials and methods
2.1. Animals, cell lines, and reagents
Adult wild-type Xenopus laevis were purchased from Hama-
matsu Seibutsukyozai Co. (Shizuoka, Japan). In vitro fertilization of
X. laevis eggs was performed as previously described [20]. Ferti-
lized embryos were dejellied in 3% cysteine hydrochloride, washed
several times in water and used for several experiments. Devel-
oping embryo stages were determined according to the scheme
described by Nieuwkoop and Faber [21]. Wild-type zebraﬁsh Da-
nio rerio AB and RW lines were kept in a light and temperature
controlled facility and maintained at optimal breeding conditions
[22]. Embryos prepared by breeding were staged according to
Kimmel et al. [23]. Human cervical carcinoma HeLa cells and
embryonal kidney HEK293 cells were cultured in Dulbecco’s
Modiﬁed Eagle’s medium with 10% fetal calf serum. An agonistic
anti-human Fas antibody, CH-11, was prepared as previously de-
scribed [24]. Anti-Flag (M2, Sigma-Aldrich, St. Louis, MO), anti-HA
(HA124, Nacalai Tesque, Kyoto, Japan), anti-Myc (9E10, Roche Di-
agnostics GmbH, Mannheim, Germany), anti-actin (MAB1501R,
Chemicon International Inc., Temecula, CA), and HRP-conjugated
anti-mouse IgG (Cell Signaling Technology, Danvers, MA, USA)
antibodies and anti-FLAG M2 afﬁnity gel (Sigma-Aldrich) were
purchased.2.2. DNA sequencing
To search for non-mammalian orthologs of the human CFLAR
gene in the NCBI DNA database, the TBLASTN program [25] was
used, and four candidate EST clones from chicken, African clawed
frog, medaka, and stickleback were identiﬁed and obtained from
distributors as described in our previous study [26]. The nucleo-
tide sequence of these clones was conﬁrmed on both strands using
TaqDyeDeoxyterminator Cycle sequencing (Applied Biosystems
Inc., Foster City, CA) on automated DNA sequencers (3130XL Ge-
netic Analyzer, Applied Biosystems Inc.).
2.3. Database search
The following web sites were used to access nucleotide and
protein sequence databases: NCBI (http://blast.ncbi.nlm.nih.gov/
Blast.cgi), Ensembl (http://www.ensembl.org/index.html), Xen-
base (http://www.xenbase.org/entry/), and ZFIN (http://zﬁn.org/
action/blast/blast). Proteins related to known c-FLIP and its para-
logous proteins were identiﬁed using TBLASTN [27]. Domain
searches were performed using either Simple Modular Archi-
tecture Research ToolSMART (SMART) (http://smart.embl-heidel
berg.de/smart/set_mode.cgi?NORMAL=1) or the Pfam database
(http://pfam.sanger.ac.uk/search). Multiple sequence alignments
were performed using Clustal W (http://www.genome.jp/tools/
clustalw/).
2.4. Molecular phylogenetic analysis
To construct a molecular phylogenetic tree, we collected pub-
lished or predicted amino acid sequences of c-FLIP and its para-
logs, CASP8, CASP10, CASP18, and CARD (caspase-recruitment
domain)-casp8 from several databases for mammals [human
(Homo sapiens), mouse (Mus musculus), opossum (Monodelphis
domestica), pig (Sus scrofa), and rat (Rattus norvegicus)], birds
[chicken (Gallus gallus) and turkey (Meleagris gallopavo)], reptiles
[anole lizard (Anolis carolinensis) and alligator (Alligator mis-
sissippiensis)], amphibian [African clawed frog (X. laevis)], ﬁsh
[catshark (Scyliorhinus canicula), coelacanth (Latimeria chalumnae),
medaka (Oryzias latipes), skate (Leucoraja erinacea), spotted gar
(Lepisosteus oculatus), stickleback (Gasterosteus aculeatus), zebra-
ﬁsh (D. rerio), and lamprey (Petromyzon marinus)], and chordates
[ascidian (Ciona intestinalis) and lancelet (Branchiostoma ﬂoridae)]
(Table A1). For phylogenetic reconstruction, the amino acid se-
quences were multiply aligned using MAFFT [28] and manually
inspected. Based on the unambiguously aligned amino acid posi-
tions in the protease-like/protease (CASc*/CASc) domain, the
phylogenetic tree was constructed by Randomized Axelerated
Maximum Likelihood (RAxML) [29] using the GAMMA-WAG ami-
no acid substitution model.2.5. Comparative modeling of non-mammalian c-FLIP proteins and
comparison with human c-FLIP
To build structural models of a CASc* domain of non-mam-
malian c-FLIP proteins, we used the crystal structure of human
c-FLIP, 3H13 [30], which has more than 25% sequence identity
with other c-FLIPs, as a template. The models were built using the
Molecular Operating Environment (MOE) software package (MOE
version 2012.10, Chemical Computing Group Inc., Tokyo), based on
the alignments calculated by FORTE, a proﬁle–proﬁle comparison
method for protein structure prediction [31], and were super-
imposed onto the structure of human c-FLIP.
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To express chicken, African clawed frog, zebraﬁsh, and medaka
c-FLIP proteins in mammalian cell lines, plasmid constructs
pME18S-Flag/GgFLIP, pME18S-Flag/XlFLIP, pME18S-Flag/DrFLIP,
and pME18S-Flag/OlFLIP were generated by fusion of the re-
spective CFLAR polymerase chain reaction (PCR)-ampliﬁed coding
sequences from EST clones of these species and the Flag-tag se-
quence, followed by insertion into a mammalian expression vector,
pME18S [32]. The pCMV-Flag/HsFLIP plasmid was generated by in-
frame inserting human CFLAR cDNA into pCMV-Tag2B (Agilent
Technologies, Santa Clara, CA). The pExpress1-GaFLIP plasmid,
which carries full-length stickleback cﬂar cDNA, was obtained
from Thermo Fisher Scientiﬁc Open Biosystems (Huntsville, AL)
and used for the expression of stickleback c-FLIP. The pCS2-XlFLIP
(DEDs) plasmid was generated by inserting a DNA fragment am-
pliﬁed by PCR into an expression vector, pCS2. The pME18S-HA/
hFADD plasmid was generated by inserting the human FADD
coding sequence fused with an HA-tag sequence into pME18S, and
pME18S-Myc/TRAF2 was generated by inserting the mouse Traf2
coding sequence fused with a Myc-tag sequence. The pCAG-Venus
plasmid, which was used to distinguish between transfected and
untransfected cells, and the pCAG-p35 plasmid, which was used to
inhibit caspase activation in transfected cells, have been previously
described [33,34]. Transfection of plasmid DNAs into HeLa and
HEK293 cells was performed using Lipofectamine and PLUS Re-
agent or LTX Reagent (Invitrogen, Carlsbad, CA), according to the
manufacturer’s instructions.
2.7. Immunoblotting and immunoprecipitation analyses
To detect human, chicken, African clawed frog, and zebraﬁsh
c-FLIP proteins in mammalian culture cells, HeLa cells were
transfected with pCMV-Flag/HsFLIP, pME18S-Flag/GgFLIP,
pME18S-Flag/XlFLIP, pME18S-Flag/DrFLIP, or pME18S, cultured for
48 h, harvested, and suspended in lysis buffer containing 50 mM
Tris–HCl (pH 7.5), 20 mM MgCl2, 0.5% Nonidet P-40, 150 mM NaCl,
and the protease inhibitor cocktails (Nacalai Tesque). After re-
moving cell debris by centrifugation, the cell lysates were added to
Laemmli sample buffer, denatured by boiling, resolved by SDS-
PAGE, and probed by immunoblotting with anti-Flag and anti-ac-
tin antibodies, respectively. After incubation with a secondary
HRP-conjugated anti-mouse IgG antibody, immune complexes
were visualized with ImmobilonTM Western chemiluminescent
reagent (Millipore Corporation, Billerica, MA), using a luminescent
image analyzer (LAS-3000, Fujiﬁlm, Tokyo, Japan).
To detect the physical association of non-mammalian c-FLIP
proteins with human FADD or mouse TRAF2 in cells, HEK293 cells
were transfected with plasmids encoding non-mammalian Flag/c-
FLIP and either plasmid pME18S-HA/hFADD or pME18S-Myc/
TRAF2. In the case of transfection with pME18S-HA/hFADD, the
plasmid pCAG-p35 was co-transfected to prevent cell death of
FADD-expressing cells. Two days after transfection, cell lysates
were prepared from transfected cells, incubated with anti-FLAG
M2 afﬁnity gel (Sigma-Aldrich) at 4 °C overnight, and the beads
were washed 5 times with lysis buffer. The immunoprecipitated
proteins were eluted with Laemmli sample buffer and analyzed by
SDS-PAGE and immunoblotting with the antibodies indicated in
the ﬁgure legends.
2.8. Cytotoxicity assays
For cytotoxicity assays, HeLa cells were transiently transfected
with pCMV-Flag/HsFLIP, pME18S-Flag/GgFLIP, pME18S-Flag/XlFLIP,
pME18S-Flag/DrFLIP, pME18S-Flag/OlFLIP, pExpress1-GaFLIP, or
pME18S in conjunction with pCAG-Venus. At 48 h aftertransfection, cells were stimulated with 250 ng/ml of CH11 and
5 μg/ml of cycloheximide (CHX). After an additional 8 h incuba-
tion, cells were ﬁxed in PBS containing 3.7% formaldehyde, washed
with PBS, and observed by phase-contrast and ﬂuorescence mi-
croscopy (DMIRE2, Leica Microsystems, Wetzlar, Germany).
2.9. Reporter assays for detection of NF-κB activation
The ability of non-mammalian c-FLIP proteins to activate NF-κB
was examined by a Dual-Luciferase Reporter Assay System (Pro-
mega, Madison, WI). Brieﬂy, the plasmids carrying the non-
mammalian CFLAR cDNAs were transfected with either reporter
plasmid pTAL-Luc or pNFκB-Luc in conjunction with another re-
porter plasmid pRL-TK into HEK293 cells. After 48 h cultivation,
cells were lysed in lysis buffer and the cell lysates were assayed for
the activities of ﬁreﬂy and sea pansy luciferases, using a multilabel
counter (ARVO-SX, PerkinElmer Life Science-Wallac Oy, Turku,
Finland).
The NF-κB activation by non-mammalian c-FLIP proteins was
also examined with another reporter plasmid, pCMV-EGFP/p65
[35]. By co-transfecting pCMV-EGFP/p65 with plasmids carrying
the non-mammalian CFLAR cDNAs, the cellular localization of an
EGFP/p65 protein was evaluated by microscopy after 48 h
cultivation.
2.10. Reverse transcription-polymerase chain reaction (RT-PCR)
analyses
Total RNAs were isolated from X. laevis embryos collected at
various stages and RT-PCR was performed as described previously
[36]. Brieﬂy, ﬁrst-strand cDNAs were ampliﬁed with two sets of
primers: primers (forward: 5’-GCCGAGCGATATGTGGTTAGAA-3’,
reverse: 5’- GCTTCAACTGGGATTTTAGGCG-3’) for the detection of
CFLAR transcripts, primers (forward: 5’-CAGCTAGCTGTGGTGTGG-
3’ and reverse: 5’-CAACATGGAAACTCACACC-3’) for the detection
of ornithine decarboxylase (ODC) transcripts as an internal control.
PCR consisted of an initial denaturation at 94 °C for 3 min followed
by 20 (CFLAR) or 18 (ODC) cycles of 94 °C for 1 min, 57 °C for 1 min,
72 °C for 1 min, and a ﬁnal extension at 72 °C for 3 min. Ampliﬁed
PCR products were analyzed by 7.5 % acrylamide-gel
electrophoresis.
Total RNAs were also isolated from zebraﬁsh embryos collected
at various stages as described previously [16]. For RT-PCR analysis,
2 μg of each RNA sample was used for ﬁrst-strand cDNA synthesis
with an oligo-dT primer on Ready-To-Go RT-PCR beads (Amer-
sham Biosciences, Arlington Heights, IL), according to the manu-
facturer's recommendations. First-strand cDNAs were ampliﬁed
with two sets of primers: primers (forward: 5’-GAAGCGCTAT-
GATTTACTACGC-3’, reverse: 5’-TTTTGGACACTTGGTTGCGTT-3’) for
the detection of cﬂar transcripts, and primers (forward: 5’-
CTGTTGACTACGGAAAGAAGT-3’, reverse: 5'-TATGTGGACGCTC-
TATGTCTA-3') for tubulin α6 (tubα6) transcripts as an internal
control. PCR consisted of an initial denaturation at 96 °C for 3 min
followed by 35 cycles of 94 °C for 45 s, 58 °C for 60 s, 72 °C for 90 s,
and a ﬁnal extension at 72 °C for 5 min.
2.11. Microinjection of synthetic mRNA into Xenopus embryos
To express a truncated form of c-FLIP in X. laevis embryos,
capped mRNA was synthesized using a template DNA, pCS2-XlFLIP
(DEDs), with the mMESSAGE mMACHINE Kit (Ambion, Austin, TX),
and puriﬁed by passing through a Sephadex G-50 column (GE
Healthcare, Arlington Heights, IL) as described previously [37].
Microinjection of synthetic mRNA into embryos was performed at
the four-cell stage. The injected embryos were statically cultured
at 17 °C overnight in 3% Ficoll and 0.1 Steinberg’s solution
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Ca(NO3)2, 83 nM MgSO4, and 0.1 mg/ml Kanamycin], then trans-
ferred in 0.1Marc’s Modiﬁed Ringers [0.5 mM HEPES (pH 7.8), 10
mM NaCl, 0.2 mM KCl, 0.2 mM CaCl2, 0.1 mM MgSO4, and 0.1 mM
EDTA] and incubated at 23 °C until the proper stages for
experiments.
2.12. Microinjection of morpholino oligonucleotide into zebraﬁsh
embryos
The antisense morpholino oligonucleotide (MO) for the coding
sequence containing the start ATG codon of the zebraﬁsh cﬂar
gene (5’-CCAGAGTAGAAAATCCATCTGCCAT-3’) and the control MO
carrying the reverse sequence (5’-TACCGTCTACCTAAAAGATGA-
GACC-3’) were obtained from GeneTools LLC (Philomath, OR) and
dissolved at a concentration of 500 mM in 1Danieau’s buffer
[5 mM Hepes (pH 7.6), 58 mM NaCl, 0.7 mM KCl, 0.6 mM Ca(NO3)2,
and 0.4 mM MgSO4]. One nanoliter of this solution or
1Danieau’s buffer was injected into one- or two-cell embryos,
which were prepared as described [38], before allowing the em-
bryos to develop at 23 °C.
2.13. Statistical analyses
Data are presented as the means and standard deviations from
at least three independent experiments. Signiﬁcant differences
between treatment groups were evaluated by calculating P values
based on Student’s t-test.3. Results
3.1. Isolation of the CFLAR/c-FLIP genes from non-mammalian ver-
tebrates and the assessment of similarities
To investigate the distribution of genes orthologous to human
CFLAR in animals, the NCBI DNA database was searched using
TBLASTN. Candidate EST clones in the chicken (G. gallus), African
clawed frog (X. laevis), medaka (O. latipes), and stickleback (G.
aculeatus) were identiﬁed. Sequencing of these EST clones led to
the determination of the complete open reading frames encoding
493, 458, 460, and 469 amino acids, respectively. Each of the
predicted amino acid sequences exhibited the highest similarity to
the long form of human c-FLIP in a reciprocal BLASTP analysis.3 As
shown in Fig. 1A, the multiple alignment of amino acid sequences
of these proteins with human and zebraﬁsh c-FLIPs veriﬁed high
similarity in two DED motifs and an inactive CASc (CASc*) domain.
Therefore, these proteins are non-mammalian orthologs of c-FLIP.
To assess the structural similarity between non-mammalian
c-FLIP proteins and human c-FLIP, three-dimensional structural
models were constructed and compared with the crystal structure
of human c-FLIP (Fig. 1B). The models showed that the core
structural elements of non-mammalian CASc* domains comprise
six β-sheets and ﬁve α-helices. When these structural models
were superimposed with a crystal structure of the human CASc*
domain, they showed a resemblance of the overall fold. Thus, the
prediction of the spatial structure indicates that the tertiary
structure of the c-FLIP family members is conserved from ﬁsh to
mammals, and is consistent with the analysis of the primary
amino acid sequence (see below).
In the CFLAR-paralogous CASP8 gene, new intron insertions
have occurred in the coding region during teleost evolution [26].
In addition, both Casp10 and CASP18 paralogous genes have been3 Data not shownlost during the evolution of various mammalian lineages [18,19].
These observations suggest that the CFLAR genes might have di-
verged during evolution. To deﬁne the genomic structure of the
CFLAR genes encoding c-FLIP proteins in vertebrates, we examined
the genomic sequences published in the NCBI, Ensembl, and
Xenbase genomic databases, and identiﬁed genomic sequences,
which cover the CFLAR cDNA sequence, from chicken, African
clawed frog, medaka, stickleback, and zebraﬁsh (Table A2). Com-
parisons of these genomic and corresponding cDNA sequences
clariﬁed the similar organization of the CFLAR genes in these ﬁve
animals. The CFLAR genes consist of nine to eleven exons. In every
case, however, the CFLAR coding region basically covered nine
exons (Fig. 1C and Table A2). Based on these data, we conﬁrmed
that the splice junction sites of the vertebrate CFLAR genes are well
conserved in both the second DED motif and a CASc* domain, al-
though they vary in position within the non-functional hinge re-
gion (Fig. 1C). Consequently, the organization of the CFLAR genes is
evolutionarily conserved and maintained in the four living classes
of vertebrates, excluding unexamined reptiles. Taken together, our
results suggest that c-FLIP proteins retain a relatively unchanged
structure during vertebrate evolution.
3.2. Molecular phylogenetic analysis of c-FLIP with its paralogous
proteins
In previous studies, we proposed that the CFLAR/c-FLIP, CASP8,
CASP10, and CASP18 genes diverged from the ancestral gene by
gene duplication during evolution of early vertebrates, and the
CARD-casp8 (tentatively named) gene in the ﬁsh lineage is also a
diverged gene because it is located next to the casp8 gene, with
sequence similarity in the protease domain [16,18]. To better un-
derstand the evolutionary conservation of c-FLIP proteins in ver-
tebrates, we constructed a molecular phylogenetic tree composed
of the CASc*/CASc domains of c-FLIP and its paralogous proteins,
CASP8, CASP10, CASP18, and CARD-casp8. For construction of the
tree, we included additional c-FLIP protein sequences from various
primitive ﬁshes, the lamprey (P. marinus, Cyclostomata), the cat-
shark (S. canicula, Chondrichthyes), the spotted gar (L. oculatus,
Actinopterygii), and the coelacanth (L. chalumnae, Sarcopterygii)
predicted from the genome and transcriptome databases, as listed
in Table A1. In addition to known amino acid sequences, we also
searched for unreported homologs in a set of sequence databases
to identify new members in the caspase-8 superfamily (Table A1).
The assembled molecular phylogenetic tree clearly indicated that
the c-FLIP subfamily forms a unique clade distinct from the other
subfamilies consisting of CASP8, CASP10, CASP18, and CARD-casp8
(Fig. 2A), suggesting that the c-FLIP subfamily members are in-
dependently evolving. In addition, the longer branch lengths of the
c-FLIP subtree suggest that the amino acid changes in c-FLIP have
quickly progressed compared with the other paralogous proteins
after the divergence of the c-FLIP clade from the other subfamilies
(Fig. 2A and B). Furthermore, comparison of the species divergence
between CASc* and CASc domains revealed that the molecular
evolutionary rate of c-FLIP is 1.7-fold higher than that of CASP8
when were analyzed in human, mouse, and chicken (Table 1).
Thus, c-FLIP seems to have evolved in its own particular way
compared to the other paralogous molecules in vertebrates.3.3. The evolutionarily conserved amino acid residues of c-FLIP fa-
mily proteins
Both histidine (H) and cysteine (C) residues in the CASc of
caspases form a catalytic dyad and are necessary for catalysis as a
cysteine protease (Fig. 3A) [39]. These two amino acid residues
Fig. 1. Analysis of the protein structures of c-FLIP proteins. (A) Multiple alignment of amino acid sequences of human, chicken, African clawed frog, medaka, stickleback, and
zebraﬁsh c-FLIP proteins. Identical and similar amino acids in all family members are indicated by red and blue, respectively. The two bold lines and a yellow box indicate the
DED motif and the protease-like CASc* domain, respectively. The numbers (1) and (2) shown above the sequences indicate the crucial arginine and tyrosine amino acid
residues, which are the cause of the deactivation of the protease activity [8], and an asterisk indicates the conserved leucine residue. (B) Structural superposition of human
c-FLIP and non-mammalian c-FLIP proteins. Structural models of the CASc* domain of chicken (light pink), clawed frog (orange), and zebraﬁsh (magenta) c-FLIP proteins
were computationally generated and superimposed with the CASc* domain of human c-FLIP (cyan, PDB ID: 3H13). (C) Comparison of the exon-intron organization of the
CFLAR genes. The splice junction sites of the CFLAR/c-FLIP genes in vertebrates are indicated by vertical lines. Their positions were deﬁned by the comparison of the
respective genomic and cDNA sequences from the species listed in Table A2. The regions corresponding to two DED motifs and a CASc* domain are indicated by blue and red
boxes, respectively.
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Fig. 2. Molecular phylogenetic analysis of c-FLIP and its paralogous proteins. (A) A molecular phylogenetic tree of c-FLIP and its paralogs, CASP8, CASP10, CASP18, and CARD-
casp8 was constructed by RAxML, based on an alignment of the protease-like/protease (CASc*/CASc) domains (145 amino acid sites without mismatches including insertion/
deletion (indel)). Human CASP3 and amphioxus CASP3-like AmphiCASP3/7 proteins were used as an out-group for rooting the tree. Numbers (in orange) at internal branches
indicate the percentage of support of that branching pattern based on a bootstrap method with 100 replicates (bootstrap probabilities). The scale bar indicates the evo-
lutionary distance of 0.2 amino acid substitutions per site. (B) A molecular phylogenetic tree restricted to the c-FLIP subfamily proteins. The tree was constructed by RAxML,
based on an alignment of the c-FLIP CASc* domains (164 amino acid sites) derived from 17 animal species including zebraﬁsh. The number (in blue) above each branch shows
branch length, while the number (in orange) beneath each internal branch shows bootstrap probability. The scale bar indicates the evolutionary distance of 0.2 amino acid
substitutions per site. The identiﬁcation numbers of the c-FLIP subfamily and its paralogous proteins shown in the tree are listed in Table A1. Abbreviations of the species: A.
ca, A. carolinensis (anole lizard); A.mi, A. mississippiensis (alligator); B.ﬂ, B. ﬂoridae (lancelet); D.re, D. rerio (zebraﬁsh); G.ac, G. aculeatus (stickleback); G.ga, G. gallus (chicken);
H.sa, H. sapiens (human); L.ch, L. chalumnae (coelacanth); L.er, L. erinacea (little skate); L.oc, L. oculatus (spotted gar); M.do, M. domestica (opossum); M.ga, M. gallopavo
(turkey); M.mu, M. musculus (mouse); O.la, O. latipes (medaka); R.no, R. norvegicus (rat); S.ca, S. canicula (catshark); S.sc, S. scrofa (pig); X.la, X. laevis (African clawed frog)
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and CARD-casp8 proteins.4 By comparing amino acid sequences,
both arginine (R) and tyrosine (Y) residues (R315 and Y360 in hu-
man c-FLIP), located in the inactive CASc* domain of c-FLIP pro-
teins, replace the histidine and cysteine residues in the other
subfamilies (Fig. 3A) [8], and are preserved in most animals ex-
amined, except lamprey, catshark, and mouse (Fig. 3B and Fig. A1).
The lamprey and catshark, which belong to the Cyclostomata and
Chondrichthyes, respectively, exhibited no conservation.4 Data not shownTherefore, these two amino acids were likely conserved after
evolving in bony vertebrates including bony ﬁsh and tetrapods
(Actinopterygii and Sarcopterygii). Furthermore, the substitution
from arginine to leucine has uniquely occurred in the mouse be-
cause the rat, which is a closely allied species to the mouse, has
retained the arginine residue. The time of divergence between
these two species is estimated at 23–33 million years ago [40,41].
As it was thought that the arginine and tyrosine residues are
crucial for the function of c-FLIP, the structural arrangement sur-
rounding these amino acid residues was examined by computa-
tional analysis. For this analysis, the leucine residue (L413 in
Table 1
Comparison of evolutionary distances (Poisson correction) and molecular evolu-
tionary rates of protease-like/protease (CASc#/CASc) domains.
compared species CASP8 CASP10 c-FLIP
human–mouse 0.239 (1.00) 0.253# (1.06) 0.434 (1.82)
human–chicken 0.392 (1.00) 0.533 (1.36) 0.688 (1.76)
mouse–chicken 0.460 (1.00) 0.592# (1.29) 0.733 (1.59)
Average 1.24 1.72
Evolutionary distances were calculated for highly homologous 179 amino acid sites
without mismatches including insertion/deletion (indel). Each value in parentheses
is relative molecular evolutionary rate normalized by the evolutionary distance of
CASP8.
# For CASP10, the amino acid sequence data of the naked mole rat (Hetero-
cephalus glaber) was used instead of the mouse because the Casp10 gene has been
lost in mice.
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tebrates (Fig. A1). Modeling veriﬁed that these three residues, ar-
ginine, tyrosine, and leucine, are capable of forming a “pseudo-
catalytic triad” (Fig. 3C). By contrast, mouse and lamprey c-FLIP
proteins may be unable to form such a ﬁrm structure (Fig. 3C).
Thus, with the exception of mouse, c-FLIP proteins have evolu-
tionarily conserved the spatial arrangement of amino acids re-
quired not only for the skeletal structure, but also for the triad
formation, while they nevertheless show characteristic differences
from the other subfamily members including CASP8, CASP10,
CASP18, and CARD-casp8.
3.4. Non-mammalian c-FLIP proteins play a role as negative reg-
ulators of apoptosis
c-FLIP plays a role as a regulator of CASP8 activation mediated
through death receptors [42]. We examined the anti-apoptotic
activity of non-mammalian c-FLIP proteins in human HeLa cells.
First, the ectopic expression of chicken, African clawed frog, and
zebraﬁsh c-FLIP proteins in transfected HeLa cell was conﬁrmed by
immunoblot analysis. To detect products in cultured cells, each
c-FLIP was tagged with the Flag epitope (Fig. 4A). Proteins with the
predicted size were detected (Fig. 4B). We then determined their
ability to protect cells from death receptor-mediated apoptotic
induction by examining the viability of transfectants subjected to
Fas-ligation. Control cells expressing only Venus, which is a variant
of yellow ﬂuorescent protein [43], were sensitive to Fas-induced
apoptosis, resulting in no Venus-positive cells after apoptotic sti-
muli (Fig. 4C). In contrast, chicken, frog, or zebraﬁsh c-FLIP-ex-
pressing HeLa cells survived even in the presence of an agonistic
anti-Fas antibody, as evidenced by the detection of only Venus-
positive cells, while untransfected cells underwent apoptosis in
the same culture dish. Similar results were observed in cells ex-
pressing medaka or stickleback c-FLIP (Fig. A2). These data in-
dicated that non-mammalian c-FLIP proteins as well as human
c-FLIP are able to protect mammalian cells from Fas-mediated
apoptotic induction. FADD is a pro-apoptotic adapter molecule
responsible for recruiting CASP8, CASP10, or c-FLIP into the death
receptor complex through homotypic DED–DED interactions
[44,45] in response to extrinsic apoptotic stimuli. We investigated
the interaction between non-mammalian c-FLIP proteins and hu-
man FADD by coimmunoprecipitation and immunoblot analyses.
Human FADD was detected in the c-FLIP complex precipitated
with an anti-Flag antibody (Fig. 4D), suggesting that non-mam-
malian c-FLIP proteins as well as human c-FLIP are able to interact
with FADD. Taken together, these results suggest that c-FLIP pro-
teins derived from birds, amphibians, and ﬁsh functionally act as
anti-apoptotic molecules in the extrinsic apoptotic pathway by
interacting with pro-apoptotic molecules.3.5. Non-mammalian c-FLIP proteins function as NF-κB activators
It was previously reported that human c-FLIP induces NF-κB
activation [14,15]. To investigate whether non-mammalian c-FLIP
proteins are also able to induce NF-κB activation, we examined
their potential in transfected cells with the dual-luciferase re-
porter assay system (Fig. 5A, B). Exogenous expression of either
chicken or clawed frog c-FLIP proteins increased the luciferase
activity in transfected HEK293 cells (Fig. 5A). This indicated that
NF-κB acquired transcriptional activity in the presence of the
exogenous c-FLIP proteins. By changing the transfection reagent,
we re-examined whether zebraﬁsh c-FLIP is able to induce NF-κB
activation. In these experiments, c-FLIP proteins derived from
zebraﬁsh and the other two ﬁsh, medaka and stickleback, in-
creased the luciferase activity in transfected cells (Fig. 5B). To
conﬁrm NF-κB activation by non-mammalian c-FLIP proteins, the
intracellular localization of p65 (RelA), an NF-κB subunit, was
checked in non-mammalian c-FLIP-expressing cells. We co-trans-
fected a plasmid, pEGFP/p65 encoding a fusion protein, EGFP/p65,
consisting of enhanced green ﬂuorescent protein (EGFP) and p65,
with plasmids encoding non-mammalian c-FLIP proteins into
HEK293 cells. The EGFP/p65 protein translocates to the nucleus
when the NF-κB signaling pathway is activated [35]. As shown in
Fig. 5C and D, EGFP/p65 nuclear localization increased in non-
mammalian c-FLIP-expressing cells relative to control cells. In this
assay system, human c-FLIP also stimulated the nuclear translo-
cation of EGFP/p65. Furthermore, the interaction between tumor
necrosis factor receptor-associated factor 2 (TRAF2) and non-
mammalian c-FLIP proteins was examined. Previous studies have
shown that TRAF2 plays a crucial role in NF-κB activation [46], and
human c-FLIP associates with TRAF2 [47]. We conﬁrmed their in-
teractions by coimmunoprecipitation and immunoblot analyses
(Fig. 5E). TRAF2 proteins were detected in the precipitated com-
plex. Taken together, these results suggest that non-mammalian
c-FLIP proteins have the ability to induce NF-κB activation in hu-
man cells.
3.6. Involvement of c-FLIP in embryonic development
In the mouse, c-FLIP is critical for embryonic development.
c-FLIP deﬁciency leads to embryonic lethality due to irregular
development of the heart [48]. To more comprehensively under-
stand the physiological roles of c-FLIP during embryonic devel-
opment in vertebrates, we investigated the expression proﬁles of
CFLAR/c-FLIP transcripts during embryogenesis of non-mammals.
First we isolated total RNAs from embryos of African clawed frog
(X. laevis) at various stages of development, and examined CFLAR
mRNA by RT-PCR. In X. laevis embryos, CFLAR mRNA was detected
in all samples prepared from stages 0, 3, 9, 13, 18, 25, and 30
(Fig. 6A). These data indicated that CFLAR mRNA exists in both
maternal and zygotic transcripts during embryogenesis. To de-
termine if CFLAR/c-FLIP is critical in embryogenesis, we generated
a plasmid construct encoding a truncated form of c-FLIP, FLIP
(DEDs), which contains only the two DED motifs (Fig. 6B), and
synthesized mRNA using this plasmid as a template. The resulting
truncated mutant protein, lacking the CASc* domain, was expected
to dysregulate the function of full-length endogenous c-FLIP in
organisms. In previous studies, discordant results have been re-
ported, with one concluding that the amino-terminal half of hu-
man c-FLIP is a weaker NF-κB activator than full-length c-FLIP [14],
whereas another study concluded that a truncated form con-
tributed to higher NF-κB activation than full-length [49]. When an
amphibian truncated form of c-FLIP was examined for its ability to
induce NF-κB activation, this mutant induced NF-κB activation to
the same extent as full-length c-FLIP in mammalian HEK293 cul-
ture cells (Fig. 6C). Following microinjection of mRNAs for FLIP
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Fig. 4. Assessment of the anti-apoptotic activity of the c-FLIP subfamily proteins. (A) The protein structure of Flag-tagged non-mammalian c-FLIP proteins consisting of two
DED motifs and a CASc* protease-like domain. (B) Immunoblot analysis of non-mammalian c-FLIP proteins. The empty vector, pCMV-Flag/HsFLIP, pME18S-Flag/GgFLIP,
pME18S-Flag/XlFLIP, or pME18S-Flag/DrFLIP were transiently transfected into HeLa cells. After culturing for 48 h, transgene products were analyzed by immunoblotting with
an anti-Flag antibody. (C) Cytological analysis of transfectants expressing non-mammalian c-FLIP proteins. HeLa cells expressing Venus with or without human, chicken,
clawed frog, and zebraﬁsh c-FLIP were incubated in the presence (lower panels) or absence (upper panels) of anti-Fas antibody and CHX for 8 h, and examined for viability by
monitoring Venus-positive cells. Both phase-contrast and ﬂuorescence images in the same ﬁeld were captured under the microscope. Scale bars represent 100 μm. (D) Co-
immunoprecipitation and immunoblot analysis of physical interactions between non-mammalian c-FLIP proteins and human FADD. Human HEK293 cells were co-trans-
fected with pME18S-HA/hFADD in conjunction with pME18S empty vector, pCMV-Flag/HsFLIP, pME18S-Flag/GgFLIP, pME18S-Flag/XlFLIP, or pME-Flag/DrFLIP. Baculovirus
p35 was introduced into all transfected cells to prevent cell death. After 2 days of cultivation, transfected cells were harvested and lysed in lysis buffer. The cell lysates were
immunoprecipitated with an anti-FLAG M2 afﬁnity gel. Coimmunoprecipitates and aliquots of cell lysates were examined by immunoblot analysis with anti-Flag, anti-HA,
and anti-actin antibodies, respectively. An asterisk indicates immunoglobulin light-chain. Abbreviations: H, human; C, chicken; F, clawed frog; Z, zebraﬁsh; IP, im-
munoprecipitation; WB, western immunoblotting.
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embryos was examined after developing to stage 45. Injection into
the equatorial areas of the two dorsal blastomeres caused abnor-
mal development of embryos associated with thorax edema
(Fig. 6D, middle panel). In contrast, abnormal embryos associated
with scoop of the abdomen were observed after microinjection of
the mRNA into the ventral area (Fig. 6D, lower panel). These
phenotypes appeared in a dose-dependent manner (Fig. 6E). These
data clearly indicate that irregular development of embryos occurs
frequently following overexpression of a truncated form of c-FLIP.Fig. 3. The speciﬁed amino acid substitutions of the CAScn domain and their evolutionary conse
CASc protease domain, and a CASc* protease-like domain are indicated by boxes, respectively.Wh
(C) for the catalytic dyad formation in CASP8, whereas the gray stars indicate arginine (R) and tyr
also coincident with positions (1) and (2), as shown in Fig. 1A. (B) A summary of critical amino a
(Y) residues are evolutionarily conserved in most bony vertebrates. In the mouse c-Flip protein, t
(F) residue instead of tyrosine is present in the catshark whereas both lysine (K) and valine (V)
species shown at the left was generated based on the previous study [70]. (C) Closeup views of th
are shown in spheres, in human, chicken, clawed frog, and zebraﬁsh c-FLIP proteins are broug
includes lysine, valine, and cysteine residues instead of the conserved amino acids, resulting in
leucine (L), there is little interaction with another leucine. The gray, red, and blue spheres indicThus, our results suggest that CFLAR/c-FLIP is involved in the early
development of clawed frog embryos.
We also investigated the function of the ﬁsh c-Flip protein in
embryonic development. The expression proﬁle of cﬂar/c-Flip
transcripts during embryogenesis in zebraﬁsh was examined
(Fig. 7A). During development, cﬂar transcripts were detected in
all samples prepared from the cleavage, gastrula, segmentation,
pharyngula, and hatching periods. These data indicate that cﬂar
mRNA exists in both maternal and zygotic transcripts during em-
bryogenesis of ﬁsh. To understand the physiological role of cﬂar/c-rvation. (A) A schematic diagram of human CASP8 and c-FLIP proteins. Two DED motifs, a
ite stars indicate the position of the essential amino acid residues, histidine (H) and cysteine
osine (Y) of c-FLIP positionally corresponding to two amino acid residues of CASP8, and are
cid residues of c-FLIP proteins conserved in vertebrates. Both the arginine (R) and tyrosine
he arginine residue is exceptionally changed to leucine. In the ﬁsh lineage, a phenylalanine
residues are present at these two critical positions in the lamprey. A taxonomic tree of the
e pseudocatalytic triad of c-FLIP proteins. The arginine, tyrosine, and leucine residues, which
ht close together in the three-dimensional shape forming a triad. In the lamprey, c-FLIP
the failure of the triad formation. As mouse c-FLIP has replaced the arginine residue with
ate C, O, and N atoms, respectively.
Fig. 5. Functional analyses of non-mammalian c-FLIP proteins on NF-κB activation ability. (A, B) Enzymatic analysis of NF-κB activation induced by non-mammalian c-FLIP
proteins. The empty vector or plasmids carrying c-FLIP were transiently co-transfected with pNFκB-Luc and pRL-TK into HEK293 cells, and cultured for 48 h. NF-κB activation
was analyzed by measuring enzyme activities of dual luciferases produced in transfected cells using a luminometer. Data are presented as the means and standard deviations
of samples counted from three independent experiments. The statistically-signiﬁcant difference between two groups was evaluated by Student’s t-test. (C) Cytological
analysis of a NF-κB component, p65, in cells expressing c-FLIP. HEK293 cells were transiently transfected with an empty vector or plasmids carrying c-FLIP together with
pEGFP/p65, and cultured for 24 h. The localization of EGFP/p65 proteins in transfected cells was analyzed by ﬂuorescence microscopy. Typical patterns of subcellular
localization of EGFP/p65: EGFP/p65 normally localizes in the cytoplasm (upper panels), but it translocates into the nucleus when the NF-κB signaling pathway undergoes
activation (lower panels) [35]. Scale bars indicate 20 μm. (D) A summary of cytological analyses on the translocation of EGFP/p65. Within each ﬁeld, positive cells (dark gray)
and negative cells (light gray) for EGFP/p65 translocation were counted under the ﬂuorescent microscope and percentages of total were calculated. N indicates the total
number of transfected cells examined in four independent experiments. (E) Co-immunoprecipitation and immunoblot analysis of physical interactions between non-
mammalian c-FLIP proteins and mouse TRAF2. HEK293 cells were transfected with either pCMV-Flag/HsFLIP, pME18S-Flag/GgFLIP, pME18S-Flag/XlFLIP, pME18S-Flag/DrFLIP,
or control vector in combination with pME18S-Myc/TRAF2. Forty-eight hours after transfection, cells were lysed and the c-FLIP complex was immunoprecipitated fromwhole
cell lysates with an anti-Flag antibody. Samples were analyzed alongside aliquots of the cell lysates by immunoblotting with anti-Flag, anti-Myc, and anti-actin antibodies,
respectively. An asterisk indicates immunoglobulin light-chain. Abbreviations: H, human; C, chicken; F, clawed frog; Z, zebraﬁsh; IP, immunoprecipitation; WB, western
immunoblotting.
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Fig. 6. Irregular development of X. laevis embryos expressing a c-FLIP mutant. (A) The expression proﬁle of African clawed frog CFLAR transcripts during embryogenesis. Total
RNAs isolated from X. laevis embryos, which were collected at indicated stages (lanes 2–8), was analyzed by RT-PCR. PCR products ampliﬁed with primers speciﬁc for CFLAR
(upper panel) and ODC (lower panel) were resolved by acrylamide-gel electrophoresis. Molecular weight markers were run in lane 1, and a negative control (NC) with no
polymerase was run in lane 9. Arrows indicate the expected molecular weights of the CFLAR and ODC PCR products, respectively. (B) The structure of a truncated c-FLIP
mutant, FLIP(DEDs), consisting of only two DED motifs. (C) Effect of a FLIP(DEDs) mutant on NF-κB activation. The empty vector or plasmids encoding intact or truncated
forms of clawed frog c-FLIP were transiently co-transfected with pNFκB-Luc and pRL-TK into HEK293 cells. After 48 h in cell culture, NF-κB activation was analyzed by
measuring enzyme activities of dual luciferases produced in transfected cells using a luminometer. Data are presented as the means and standard deviations of samples
counted from three independent experiments. The statistically-signiﬁcant difference between two groups was evaluated by Student’s t-test. (D) Morphological analysis of
embryos expressing FLIP(DEDs). X. laevis embryos were injected without (upper panel) or with mRNA encoding FLIP(DEDs), at the equatorial area of two dorsal (middle
panel) or two ventral (lower panel) blastomeres at the four-cell-stage. Images of the developing embryos were acquired at stage 45. Arrowheads indicate the edema and
abdominal constriction of the injected embryos, respectively. Scale bars indicate 1 mm. (E) A summary of the phenotypic data presented in (D). Embryos displaying edema
(red), abdominal constriction (dark blue), bending (light blue), and other defects (black) were counted under the microscope. Data represent the percentages calculated from
ﬁve independent experiments. Abbreviations: D, dorsal; V, ventral.
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morpholino oligonucleotide speciﬁc to cﬂar/c-Flip, cﬂar-MO, in the
developing embryos. We injected cﬂar-MO into the fertilized eggs
and examined the morphology of embryos during development.
We observed abnormal development of the injected embryos in a
dose-dependent manner, resulting in thorax edema and the de-
layed velocity of red blood cell ﬂow or the clogging of red blood
cells (Fig. 7B). We statistically conﬁrmed these abnormalities(Fig. 7C). Thus, the deregulation of c-FLIP expression derailed
embryonic development, suggesting the involvement of c-FLIP in
embryogenesis.
4. Discussion
In this study, in order to understand the ubiquity and diversity
of the c-FLIP/CFLAR subfamily members during vertebrate
Fig. 7. Developmental anomalies in zebraﬁsh embryos with knockdown of cﬂar transcripts. (A) The expression proﬁle of zebraﬁsh cﬂar transcripts during embryogenesis.
Total RNAs isolated from embryos, which were collected at 1, 6, 18, 36, and 48 h after fertilization (lanes 2–6), was analyzed by RT-PCR. PCR products ampliﬁed with primers
speciﬁc for cﬂar (upper panel) and tubulin α6 (tubα6) (lower panel) were resolved by agarose-gel electrophoresis. Molecular weight markers were run in lane 1, and a
negative control (NC) with no template DNA was run in lane 7. Arrows indicate the expected positions of the cﬂar and tubα6 PCR products, respectively. (B) Morphological
analysis of developing embryos subjected to morpholino oligonucleotide (MO) injection. Fertilized eggs were injected with an antisense MO for cﬂar, cﬂar-MO and their
development was monitored under the microscope. Images of the developing embryos were acquired at three days later. The resulting abnormal phenotypes consisted of
edema (middle panel) and a cluster of blood cells in the vessel (right panel), indicated by an arrow. (C) A summary of the phenotypic data presented in (B). Embryos
displaying the edema (red) or irregular ﬂow of red blood cells (blue) were counted under the microscope. Data represent the percentages calculated from four independent
experiments.
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proteins. The three-dimensional structure analysis showed a si-
milar skeletal structure in vertebrate c-FLIP proteins. In addition,
the arginine and tyrosine residues located in the pseudocatalytic
triad of the CASc* domain are conserved in most bony vertebrates.
Non-mammalian c-FLIP proteins functionally retain their potential
as both apoptosis-regulating molecules and inducers of NF-κB
activation. These results provide evidence that c-FLIP proteins are
evolutionarily conserved in protein structure and function across
vertebrate species. This prompts the hypothesis that these con-
served functions were already established in the ﬁsh ancestor. Onthe other hand, the phylogenetic analysis veriﬁed that, compared
with paralogous proteins such as CASP8, c-FLIP proteins have a
faster substitution rate of amino acids in the CASc*/CASc domains,
although they have preserved several amino acids that might be
critical for maintenance of the structure and functionality. Con-
sequently, c-FLIP, which arose at an early stage of vertebrate
evolution, still might be continuing its molecular evolution while
keeping the core structures.
In our previous studies, we proposed that the CFLAR, CASP8,
CASP10, and CASP18 genes have been tandemly-duplicated from a
single ancestral gene in the course of vertebrate evolution [16],
K. Sakamaki et al. / Biochemistry and Biophysics Reports 3 (2015) 175–189 187and we and another group showed that both CFLAR and CASP8
genes invariably exist in vertebrates, whereas the other two genes,
CASP10 and CASP18 have been lost in some mammals [16–18]. The
main function of c-FLIP seems to be the regulation of CASP8 ac-
tivation, but it is restricted to the vertebrate lineage. As supporting
evidence for such a lineage speciﬁcity, no orthologs of c-FLIP have
been reported in the fruit ﬂy Drosophila melanogaster and ascidian
Ciona intestinalis databases, while CASP8 exists in both animals
[50, 51]. To understand the appearance and the acquisition of the
functional properties of c-FLIP in the process of evolution, the
investigation of jawless ﬁsh, such as lamprey and hagﬁsh, is
helpful because lamprey c-FLIP protein has not yet been char-
acterized with regard to its functionality, and it clearly exhibits
differences in the protein structure relative to other c-FLIP
proteins.
c-FLIP was previously identiﬁed as a regulator of death re-
ceptor-mediated apoptosis. Whereas the deﬁciency of these death
receptors causes no irregular embryogenesis [52], c-FLIP-deﬁcient
mice died at mid-gestation during embryogenesis due to irregular
development of the heart [48]. This suggests that c-FLIP functions
during embryonic development independent of death receptor-
mediated signal transduction. A recent study reported that c-FLIP
is indispensable for limited activation of CASP8 during embryonic
development of rodents [53]. Therefore, c-FLIP and CASP8 act in a
coordinated manner during embryogenesis. Apart from their re-
spective roles in apoptosis, these proteins suppress necroptotic cell
death mediated by receptor-interacting serine/threonine kinases
1 and 3 (RIPK1 and RIPK3) are involved in [53–55]. Necroptosis is a
form of regulated or programmed necrosis and its signaling
pathway has been deﬁned [55–61]. When CASP8 is inactive and
hence unable to control RIPK1, the necroptotic signaling pathway
is activated: RIPK1 is free to interact with and phosphorylate
RIPK3, and activated RIPK3 phosphorylates and activates an ef-
fector molecule, mixed lineage kinase domain-like (MLKL), re-
sulting in cell death. These core components required for ne-
croptosis are also detectable in non-mammalian vertebrates by
searching the database.5 It is thus likely that a major develop-
mental role of vertebrate c-FLIP in conjunction with CASP8 may be
to jointly antagonize the induction of necroptotic cell death, al-
though the molecular mechanism of the c-FLIP and CASP8 co-
ordination still remains elusive [55, 60–62]. Interestingly, we no-
ticed that the phenotypes of clawed frog embryos expressing a
truncated mutant of c-FLIP are morphologically similar to those of
embryos exogenously expressing a protease-deﬁcient mutant of
CASP10β [63]. This observation suggests that a CASP8 paralog,
CASP10 also works with c-FLIP in developing embryos. Thus, c-FLIP
might have pivotal roles not only for regulation of apoptosis as-
sociated with CASP8 activation but also for development and/or
proliferation.
It has been reported that c-FLIP is required for heart develop-
ment during mouse embryogenesis [48]. In humans, the expres-
sion of c-FLIP was detected in endothelial cells of the coronary
arteries [64]. In addition, human umbilical vein endothelial cells
(HUVECs) and dermal and pulmonary microvascular endothelial
cells (MVECs) have been reported to express c-FLIP [65,66]. In our
study, both clawed frog embryos expressing a mutant FLIP(DEDs)
and zebraﬁsh embryos with down-regulated cﬂar expression ex-
hibited edema during development (Figs. 6 and 7). Edema is
thought to be swelling caused by ﬂuid leakage from the vascular
system [67]. Both lines of evidence strongly suggest that c-FLIP
plays a role in angiogenesis.5 Data not shown5. Conclusions
We demonstrated the universal functionality of c-FLIP proteins
during vertebrate evolution. In vertebrates, the c-FLIP subfamily
members commonly function as a negative regulator of the ex-
trinsic apoptosis associated with CASP8 activation, and as an in-
ducer for NF-κB activation. Although these physiological actions of
c-FLIP proteins might be the result of the deﬁciency of protease
activity, the speciﬁc amino acid substitutions in the catalytic dyad
of the caspase domain and their conservation during evolution
under selective pressure are striking, suggesting the possibility
that c-FLIP has acquired a new function, not merely the loss of the
enzyme activity, as was proposed previously [68]. Previous studies
have shown that regardless of cell death, c-FLIP functions as a
modulator of the Wnt signaling pathway [69], and an activator of
the Erk signaling pathway [15]. Therefore, future studies should be
directed at investigating the molecular mechanisms by which
c-FLIP acts as a new functional molecule with interactions apart
from caspase signaling.Acknowledgments
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